financetom
Business
financetom
/
Business
/
Chubb Q3 Operating Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chubb Q3 Operating Earnings, Revenue Rise
Oct 21, 2025 1:37 PM

04:20 PM EDT, 10/21/2025 (MT Newswires) -- Chubb ( CB ) reported Q3 operating earnings late Tuesday of $7.49 per diluted share, up from $5.72 a year earlier.

Analysts polled by FactSet expected $6.17.

Net premiums written by the insurer for the three months ended Sept. 30 were $14.87 billion, up from $13.83 billion a year earlier.

Analysts surveyed by FactSet expected total revenue of $12.98 billion.

Shares of Chubb ( CB ) rose almost 1.3% during after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ulta Beauty's annual profit forecast misses estimates as costs climb
Ulta Beauty's annual profit forecast misses estimates as costs climb
Mar 14, 2024
(Reuters) - Ulta Beauty ( ULTA ) on Thursday forecast full-year profit below Wall Street estimates after elevated supply chain costs and increased promotions hurt margins, sending its shares down 4.5% in extended trading. Despite the beauty retailer's efforts to boost sales through steep discounts, inflation-weary consumers cut back spending on discretionary items such as cosmetics and hair care products....
Aquestive Therapeutics' Anaphylm Demonstrates Faster Maximum Concentration Reach in Phase 3 Trial
Aquestive Therapeutics' Anaphylm Demonstrates Faster Maximum Concentration Reach in Phase 3 Trial
Mar 14, 2024
06:00 PM EDT, 03/14/2024 (MT Newswires) -- Aquestive Therapeutics ( AQST ) said Thursday its sublingual film epinephrine experimental drug Anaphylm showed exposure levels comparable to autoinjectors and was quicker to reach maximum concentration in a phase 3 study. The two-part study focused on pharmacokinetics, the way a drug is absorbed, and pharmacodynamics, the way it affects the body, of...
Antero Resources Insider Sold Shares Worth $736,357, According to a Recent SEC Filing
Antero Resources Insider Sold Shares Worth $736,357, According to a Recent SEC Filing
Mar 14, 2024
06:01 PM EDT, 03/14/2024 (MT Newswires) -- Sheri Pearce, Senior Vice President, Accounting and Chief Accounting Officer, on March 13, 2024, sold 28,009 shares in Antero Resources ( AR ) for $736,357. Following the Form 4 filing with the SEC, Pearce has control over a total of 106,698 shares of the company, with 106,698 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1433270/000110465924034602/xslF345X03/tm248897-1_4seq1.xml...
Wood pellet maker Enviva previews contract shakeup in bankruptcy
Wood pellet maker Enviva previews contract shakeup in bankruptcy
Mar 14, 2024
* Enviva ( EVA ) restructuring aims to cut $1 billion in debt * Company seeks to renegotiate long-term biofuel contracts * German energy co RWE says it is owed $349 million By Dietrich Knauth NEW YORK, March 14 (Reuters) - Bankrupt wood pellet manufacturer Enviva Inc ( EVA ) plans to renegotiate long-term biofuel supply agreements and resolve a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved